Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer

Fig. 7

Network Diagram: Discontinuation due to AEs (Base-case Analysis). Abbreviations: AE = adverse event; CAP = capecitabine; ERI = eribulin; GEM = gemcitabine; IXA = ixabepilone; TPC = treatment by physician’s choice; UTI = utidelone; VIN = vinorelbine

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us